On November 16, Camtek fell 5.02% in Pre-Market Trading, trading at $96.62/share, with turnover of $785,800.
The latest identifiable catalyst was continued pressure from analyst target-price reductions and cautious valuation commentary. B. Riley recently lowered its target to $138 from $166 while maintaining a Buy rating, after Morgan Stanley downgraded the stock to Underweight with a $126 target and flagged intensifying competition in 2D inspection, pricing pressure from packaging customers, and limited room for error at a rich valuation.
Fundamentally, Camtek's latest quarterly update showed mixed execution rather than a major guidance reset. Third-quarter adjusted EPS was $0.99 versus the $1.00 consensus, while revenue rose to $161.3 million from $126.0 million and slightly exceeded one set of expectations. The company reiterated Q4 revenue guidance of about $180 million, full-year revenue of about $595 million, and a 2027 revenue outlook above $800 million, suggesting the current share weakness is more closely tied to valuation and competitive concerns than to a change in company guidance.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments